tert-butyl 4,4-difluoro-3-(2-methoxy-2-oxoethyl)piperidine-1-carboxylate, 95.0%, 250mg

2-Tert-butyl-4-[(3-chlorophenyl)methylidene]-1,2,3,4-tetrahydroacridine-9-carboxylic acid, 95%, 100mg

4-Phenyl-2-pyrrolidone, 95.0%, 25g

4-Benzyl N-Carbobenzoxy-L-aspartate>98.0%(HPLC)(T)25g

N-(2-Amino-4-trifluoromethylphenyl)morpholine, 97.0%, 500mg

1-(4-Nitrophenyl)imidazole, 98.0%, 10g

Sample beakers with screw closure with graduation and labelling area, 60 ml, Non-sterile, 600 Piece(s)

(R)-4-Hydroxy-piperidin-2-one, 97.0%, 250mg

3-(5-Methyl-2-thienyl)-2-propenoic acid, 98%, 5g

3-Bromo-7-methoxyquinoline, 95.0%, 5g

2'-Fluorobiphenyl-3-carbaldehyde, 1g

Di(alpha-phenylethyl) Sulfide (DL- and meso- mixture)25g

2-Bromocarbazole, 99.0%, 5g